Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
01/2005
01/19/2005EP1497326A1 Prothrombin activating protein
01/19/2005EP1497325A1 Two green fluorescent protein fragments and their use in a method for detecting protein - protein interactions
01/19/2005EP1497324A2 CD4 sp + /sp T-LYMPHOCYTE-SPECIFIC HEPATITIS C VIRUS EPITOPES
01/19/2005EP1497323A1 Multiple branch peptide constructions comprising from 2 to 16 branches of the peptide rqgys or from 8 to 16 branches of the peptide rqgy providing from the hiv gp41 glycoprotein
01/19/2005EP1497322A2 Treatment of infections and other disorders
01/19/2005EP1497321A1 Immunological methods and compositions for the treatment of alzheimer's disease
01/19/2005EP1497320A2 New gene expressed in prostate cancer and methods of use
01/19/2005EP1497319A2 Cell adhesion and extracellular matrix proteins
01/19/2005EP1497318A2 Binding molecules for fc-region polypeptides
01/19/2005EP1497315A2 Nucleic acid-associated proteins
01/19/2005EP1497313A2 Immunogenic peptide composition for the prevention and treatment of alzheimer's disease
01/19/2005EP1497311A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
01/19/2005EP1497307A2 Recombinant p.falciparum merozoite protein-1 42 vaccine
01/19/2005EP1497306A1 Alternatively spliced nucleic acid molecules
01/19/2005EP1497305A2 Insulin-responsive dna binding protein-1 and methods to regulate insulin-responsive genes
01/19/2005EP1496980A2 Compositions and methods for the acceleration of protein secretion dynamics
01/19/2005EP1496945A1 Mycoplasma polypeptides
01/19/2005EP1496944A2 Improved raav expression systems for genetic modification of specific capsid proteins
01/19/2005EP1496939A2 Modified cea nucleic acid and expression vectors
01/19/2005EP1496938A2 Particle-bound human immunodeficiency virus envelope glycoproteins and related compositions and methods
01/19/2005EP1496935A2 Insulin and igf-1 receptor agonists and antagonists
01/19/2005EP1496930A2 G-type peptides to ameliorate atherosclerosis
01/19/2005EP1496926A1 Use of transthyretin peptide/protein fusions to increase the serum half-life of pharmacologically active peptides/proteins
01/19/2005EP1496925A2 Use of interleukin-24 to treat ovarian cancer
01/19/2005EP1496924A2 Treatment of gastroparesis
01/19/2005EP1496923A1 Cancer immunotherapy
01/19/2005EP1496886A1 Knockout mice and their use
01/19/2005EP1496879A1 Regulation of a novel colon specific retinol dehydrogenase by apc and cdx2
01/19/2005EP1496834A2 High affinity integrin polypeptides and uses thereof
01/19/2005EP1496743A2 Compositions and methods for the therapy and diagnosis of lung cancer
01/19/2005EP1496737A2 .ce1, a regulator of cold induced transcriptome and freezing tolerance in plants
01/19/2005EP1463942A4 Methods for purifying protein
01/19/2005EP1458760A4 Entrapped binding proteins as biosensors
01/19/2005EP1411762A4 Combinations of genes for producing seed plants exhibiting modulated reproductive development
01/19/2005EP1404708A4 Non-endogenous, constitutively activated versions of plant g protein-coupled receptor: gcr1
01/19/2005EP1392366A4 Nuclear receptor-mediated introduction of a pna into cell nuclei
01/19/2005EP1379283A4 Identification of target-specific folding sites in peptides and proteins
01/19/2005EP1070081A4 Novel molecules of the t129-related protein family and uses thereof
01/19/2005EP0918863B1 Frozen food product containing heat stable antifreeze protein
01/19/2005EP0862580B1 Streptoccal inhibitor of complement-mediated lysis, protein sic
01/19/2005EP0821737A4 NUCLEOTIDE SEQUENCE OF THE HAEMOPHILUS INFLUENZAE Rd GENOME, FRAGMENTS THEREOF, AND USES THEREOF
01/19/2005EP0789588B1 Method for making a medicament for treating secondary immunodeficiency
01/19/2005EP0545946B1 Growth-promoting agent
01/19/2005CN1568369A Hybrid interferon/interferon Tau proteins, compositions and methods of use
01/19/2005CN1568330A Glycosylphosphatidylinositol containing polypeptides
01/19/2005CN1568329A Immunogenic peptide composition for the prevention and treatment of Alzheimer's disease
01/19/2005CN1568306A Hydroxamic acid thrombospondin peptide analog that inhibits aggrecanase activity
01/19/2005CN1568195A Peptide YY and peptide YY agonists for treatment of metabolic disorders
01/19/2005CN1568141A TYRA gene and its application
01/19/2005CN1566346A Expression and separation purification for S-protein of recombinant SARS coronavirus
01/19/2005CN1566345A Homologous sequence linked with yellow dwarf-resistant gene Bdv2 and use thereof
01/19/2005CN1566342A Antigenic epitope of S-protein of SARS coronavirus, antibody of S-protein of SARS coronavirus , nucleic acid encoding S-protein of SARS coronavirus and compositions containing same
01/19/2005CN1566154A Novel hepatocyte growth factor, preparing process and application thereof
01/19/2005CN1566153A Method for separating and extracting saccule peptides from saccules rotundus of rabbits
01/19/2005CN1566152A Immunoreactive peptide Trpi possessing antibacterial action
01/19/2005CN1566151A Sugar latticeing material CHB extracted from serum of turtle or/and tortoise, preparation process and application in pharmacy thereof
01/19/2005CN1566150A Human amyloid precursor protein 639, coded sequence and uses thereof
01/19/2005CN1566149A Immunosuppressive receptor derived from dendritic cell, coded sequence and uses thereof
01/19/2005CN1566148A Tumor suppressor, coded protein and application thereof
01/19/2005CN1566147A Transcription factor for regulating and controlling gibberellin generation, coded gene and application thereof
01/19/2005CN1566146A Paddy rice stalk extension gene, coded protein and application thereof
01/19/2005CN1566145A Polyvalent pneumococcal polysaccharide combination vaccine
01/19/2005CN1566144A Functional protein in SARS coronavirus
01/19/2005CN1566143A Antigenic determinant of SARS coronavirus nucleocapsid protein and application thereof
01/19/2005CN1566142A Polypeptide drug for inhibiting SARS coronavirus from infecting host cell
01/19/2005CN1566134A Non-structural protein gene of coronavirus and use thereof
01/19/2005CN1565627A Hemoglobin alpha chain peptide fragments useful for inhibiting stem cell proliferation
01/19/2005CN1565624A Carbowaxing recombiant human growth hormone medicine and its preparation process
01/19/2005CN1185350C DNA comprising rice anther-specific gene and transgenic plant transformed therewith
01/19/2005CN1185348C Chimeric interleukin-6 soluble receptor/ligand protein and application thereof
01/19/2005CN1185344C Protein for blocking platelet adhesion
01/19/2005CN1185343C New growth-differentiation factor of the TGF-beta family
01/19/2005CN1185341C Method for preparing medicine using silkworm expressed human beta interferon
01/19/2005CN1185340C Method for producing medicine using silkworm expressed human alpha2b interferon
01/19/2005CN1185258C Trivalent chromium composition and its use
01/19/2005CN1185257C Glucagon insulinotropic complexes, compositions and methods
01/19/2005CN1185256C Rice tiller control gene MOC1 and its application
01/19/2005CN1185255C Compositions and Methods for detecting treponema pallidum
01/19/2005CN1185254C First hypervariable region antigen of hepatitis C and fusion antigen
01/19/2005CN1185253C Neoglycoproteins
01/19/2005CN1185252C Somatostatin peptides
01/19/2005CN1185248C Ribosomal deactivated protein gene
01/18/2005US6845328 Detection of enzyme modulators; obtain three dimensional structure of enzyme, design modulator to bind active site, incubate with test modulator, monitor adjustment in enzyme activity
01/18/2005US6844486 Nac1—a plant gene encoding a transcription factor involved in cotyledon and lateral root development
01/18/2005US6844432 Hybrid detector; amplification
01/18/2005US6844431 Nucleic acid encoding spinocerebellar ataxia-2 and products related thereto
01/18/2005US6844427 Method for removing the transforming growth factor-β by adsorption
01/18/2005US6844423 Polypeptide for use in the diagnosis, prevention and treatment infections
01/18/2005US6844422 Inhibitor protein of the wnt signal pathway
01/18/2005US6844421 Inhibit undesired human CD4+ T cell immune responses and can be used to treat disease such as multiple sclerosis and to prevent graft rejection and graft versus host disease
01/18/2005US6844327 Gene therapy approaches to supply apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
01/18/2005US6844326 Treatment of alopecia
01/18/2005US6844325 Compositions for the treatment and diagnosis of breast cancer and methods for their use
01/18/2005US6844323 Polypeptide-calcitonin 11 and the polynucleotide encoding it
01/18/2005US6844321 Preparing an aqueous solution comprising glucagon-like peptide-1 (GLP-1), analogue, a salt, and an organic solvent, isolation of the crystals after formation
01/18/2005US6844319 Targeting Hepatic Stellate Cells (HSC) involved in sclerotic and/or fibrotic diseases with carrier linked to amino acid sequence SRNLIDC
01/18/2005US6844315 Determining peptide's therapeutic effect by administering to subject prone to showing signs of diabetes; determining development of diabetes
01/18/2005US6844193 Detecting ligand for fibroblast growth factor binding protein; obtain nucleotide sequence libraries, obtain cells, transform cell with nucleotide sequences, monitor kinase activity, amplified activity indicates presence of ligand
01/18/2005US6844192 Preparing preferential viral vectors; provide packaging cell, transfect with nucleotide sequences coding viral vector, culture transfected cells, recover packaged vector
01/18/2005US6844190 Binding protein for use in the treatment of pain, schizophrenia, depression, obsessive compulsive disorder, anxiety, migraines and pain